GenentechOvjeren akaunt

@genentech

Official Twitter Site for Genentech. See our community guidelines here:

USA
Vrijeme pridruživanja: rujan 2008.

Tweetovi

Blokirali ste korisnika/cu @genentech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @genentech

  1. 31. sij

    We were named one of the for Commuters! One of our 2020 sustainability goals is to reduce CO2 emissions from transportation activities by 10%. Learn more about our efforts to create an environmentally sustainable future:

    Poništi
  2. 28. sij

    This National , learn how more than 1,300 of our employees volunteer their time as mentors to inspire the next generation of scientists, innovators and critical thinkers.

    Poništi
  3. 28. sij

    Check out our new study in from Jason Hackney and colleagues which identifies causal genes for age-related macular degeneration, a leading cause of vision loss.

    Poništi
  4. 28. sij

    ICYMI: The is reviewing our combination for the most common type of under its Real-Time Oncology Review pilot program. Learn more:

    Poništi
  5. 27. sij

    We're proud to help support this important research initiative around in clinical trials with our partner !

    Poništi
  6. 27. sij

    Is it possible to extend human health? Check out the final episode of Season 3 to learn how we might be able to engage our body's own repair mechanisms to delay the onset of age-related disease.

    Poništi
  7. 27. sij

    : Our combination for the most common type of is being reviewed under the Real-Time Oncology Review pilot program, which aims to get treatments to patients faster.

    Poništi
  8. 24. sij

    Today we shared an update on our Phase III study evaluating our immunotherapy for a specific type of bladder cancer. Learn more:

    Poništi
  9. 23. sij

    : Pivotal trial evaluating our spinal muscular atrophy () medicine meets primary endpoint in infants with Type 1

    Poništi
  10. proslijedio/la je Tweet
    22. sij

    “We are going after multiple TCRs against multiple targets simultaneously...that’s why we’re excited about this strategy” - CSO Harlan Robins, with VP, Cancer Immunology, Ira Mellman at Learn more about our partnership:

    Poništi
  11. proslijedio/la je Tweet
    21. sij

    Cancer mutations create neoantigens that are of great interest for immunotherapy, but their accurate identification remains a challenge. researchers show that mutation position is an important determinant for immunogenicity

    Poništi
  12. proslijedio/la je Tweet
    21. sij

    Join co-founder & Chief Scientific Officer, Harlan Robins, and Vice President, Cancer Immunology, Ira Mellman at for a fireside chat on progress, challenges, and what’s next for cancer immunotherapy. Read more about our partnership:

    Poništi
  13. 21. sij

    Tomorrow at , Ira Mellman, Vice President, Cancer Immunology, joins Co-founder & Chief Scientific Officer, Harlan Robins, for a fireside chat on cancer immunotherapy. Read more about our partnership with Adaptive.

    Poništi
  14. 21. sij

    We’re honored to be named one of Best Employers for Diversity! Learn how we’re fostering a culture where difference is valued and celebrated:

    Poništi
  15. 17. sij

    Neoantigens result from cancer-specific genetic mutations. In , a team led by Aude-Hélène Capietto, Suchit Jhunjhunwala & Lélia Delamarre identify traits of these mutations that could help prioritize targets for future cancer .

    Poništi
  16. 17. sij

    Looking for in-flight entertainment on your way home from ? Tune in to our latest episode to hear from Mark Lee and David Shames about how could help deliver personalized care to those who need it.

    Poništi
  17. 16. sij

    DYK that of the nearly 4,000 “druggable” targets known today, only about a quarter have been drugged or have a medicine that can impact them? See how we’re working to address this long-standing challenge with our partners.

    Poništi
  18. 15. sij

    Solving the challenges facing the healthcare industry is best tackled as a team. That’s why we have 220 ongoing around the world. Learn more about our continued commitment to .

    Poništi
  19. 15. sij

    No single institution can change anything as sophisticated and complex as healthcare. See how our partnerships are helping to usher in a new age of .

    Poništi
  20. 14. sij

    Congrats to Dr. Sandra Horning for being selected as 's Woman of the Year! We're thankful for her incredible contributions to medicine & to our employees who have been inspired by her commitment to science, patients & women in leadership.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·